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Therapeutic hypothermia in patients following
traumatic brain injury: a systematic review
Steven Dunkley and Anne McLeodAQ1
ABSTRACT
Background: The efficacy of therapeutic hypothermia in adult patients with traumatic brain injury is not fully understood. The historical use of therapeutic hypothermia at extreme
temperatures was associated with severe complications and led to it being discredited. Positive results from animal studies using milder temperatures led to renewed interest. However,
recent studies have not convincingly demonstrated the beneficial effects of therapeutic hypothermia in practice.
Aim: This review aims to answer the question: in adults with a severe traumatic brain injury (TBI), does the use of therapeutic hypothermia compared with normothermia affect
neurological outcome?
Design: Systematic review.
Method: Four major electronic databases were searched, and a hand search was undertaken using selected key search terms. Inclusion and exclusion criteria were applied. The
studies were appraised using a systematic approach, and four themes addressing the research question were identified and critically evaluated.
Results: A total of eight peer-reviewed studies were found, and the results show there is some evidence that therapeutic hypothermia may be effective in improving neurological
outcome in adult patients with traumatic brain injury. However, the majority of the trials report conflicting results. Therapeutic hypothermia is reported to be effective at lowering
intracranial pressure; however, its efficacy in improving neurological outcome is not fully demonstrated. This review suggests that therapeutic hypothermia had increased benefits in
patients with haematoma-type injuries as opposed to those with diffuse injury and contusions. It also suggests that cooling should recommence if rebound intracranial hypertension
is observed.
Conclusion: Although the data indicates a trend towards better neurological outcome and reduced mortality rates, higher quality multi-centred randomized controlled trials are
required before therapeutic hypothermia is implemented as a standard adjuvant therapy for treating traumatic brain injury.
Relevance to clinical practice: Therapeutic hypothermia can have a positive impact on patient outcome, but more research is required.
Key words: intracranial pressure • neurological outcome • systematic review • therapeutic hypothermia • traumatic brain injury
BACKGROUND
Traumatic brain injury (TBI) is a leading
cause of death and disability, with around
7⋅7 million people living with TBI-related
disabilities in the European Union (Stoc-
chetti et al., 2015). Severity is diagnosed
using radiological criteria (Bersten et al.,
2014) along with the Glasgow coma scaleAQ2
(GCS), with a GCS of 3–8 signifying severe
injury (Maas et al., 2008). In severe TBI,
the primary injury (diffuse damage and
contusions) can lead to the development
of a secondary injury (cerebral oedema
and/or haematomas) (Bersten et al., 2014).
TBI management primarily focuses on
maintaining adequate cerebral blood low
(CBF), controlling intracranial pressure
(ICP) <20mmHg and reduction of neuronal
metabolic requirements through the use
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of, for example, sedation (Brain Trauma
Foundation, American Association of Neu-
rological Surgeons (AANS), Congress of
Neurological Surgeons (CNS), AANS/CNS
Joint Section on Neurotrauma and Critical
Care, 2007).
Therapeutic hypothermia (TH) is the
induced cooling of patients to 32–35∘C and
is proposed to ameliorate the mechanisms
of secondary brain injury, improving neuro-
logical outcome by decreasing free radical
production, preserving the blood–brain bar-
rier (BBB), attenuating ionic disruption and
inhibiting excitatory amino-acid release.
This inhibits the formation of cerebral
oedema and lowers ICP (Busto et al., 1989;
Smith and Hall, 1996). Three studies in the
early 1990s documented that TH lowered
ICP and improved neurological outcome
compared to normothermic patients (Clifton
et al., 1993; Marion et al., 1993; Shiozaki et al.,
1993). However, a subsequent study by
Clifton et al. (2001) found that TH did
not lead to improved neurological outcome.
Further studies reported limited success and
have failed to provide statistically signii-
cant evidence advocating its use (Chen et al.,
2001; Shiozaki et al., 2001, 2003). Refrac-
tory intracranial hypertension (IH) during
re-warming of patients has been noted,
suggesting that TH delays the pathological
processes of brain injury rather than pre-
venting injury. However, the trend towards
improved neurological outcomes means TH
remains an area of research, with guidelines
suggesting that TH for more than 48 h may
reduce mortality (Brain Trauma Founda-
tion, American Association of Neurological
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Surgeons (AANS), Congress ofNeurological
Surgeons (CNS), AANS/CNS Joint Section
on Neurotrauma and Critical Care, 2007).
AIM AND OBJECTIVES
The aim of this review is to appraise recent
research examining the effects of TH in
patients with TBI to answer the question
in adults with a severe TBI, does the use
of TH compared with normothermia affect
neurological outcome?
Secondary objectives are:
1. Investigate the relationship between
TH and ICP.
2. Identify relationships between brain
pathology and effectiveness of TH.
3. Identify any complications associated
with TH.
4. Consider future implications for
practice.
METHODOLOGY
Search strategy
A comprehensive search of the PubMed,
MEDLINE, CINAHL and Cochrane Library
databases was undertaken to identify
peer-reviewed primary research investi-
gating the effects of TH in adult patients
with TBI. The following search terms, which
incorporated MeSH terms, were used:
‘cool*’ OR ‘hypotherm*’ OR ‘temperature
management’ AND ‘traumatic brain injury’
OR ‘TBI’ OR ‘head injury’ OR ‘IH’ OR ‘ICP’.
The reference lists of selected studies were
also manually searched as were the contents
of relevant journals.
Selection criteria
During the selection process, the following
inclusion criterionwas applied: articles pub-
lished in English, primary research, involve
adult patients, investigate the effectiveness
of induced hypothermia for traumatic brain
injury and published since 2004. Articles
were excluded if they considered TH follow-
ing stroke, spontaneous intracerebral bleeds,
hepatic encephalopathy or cardiac arrest.
In addition, studies investigating different
methods of inducing hypothermia, measur-
ing ICP, cerebral perfusion or blood low
were excluded.
Quality assessment
Identiied literature was screened for rele-
vance using a three-stage process ensuring
a systematic approach. Firstly, the title
was reviewed, and following this, the
abstract was reviewed to ensure the inclu-
sion/exclusion criteria were adhered to. The
third stage of screening involved reviewing
the studies in full to ensure all fulilled the
search criteria. Both authors undertook the
review process independently and then
agreed on the eligibility of the studies for
inclusion.
Data extraction and appraisal
The two authors extracted the data, such
as methodology, sample sizes and statistics
(mean scores, standard deviation, p values),
from each included study using a standard-
ized extraction form. Outcomes for neuro-
logical outcome at different time pointswere
extracted as well as other data recorded dur-
ing the study (such as ICP). The eligible
studies were appraised using either the crit-
ical appraisal skills programme (CASP) ran-
domized controlled trial (RCT) checklist or
the CASP cohort study checklist depending
on research methodology/design.
Findings
Search outcome
The initial electronic search yielded 122
results (excluding duplicates) once inclu-
sion/exclusion criteria were applied
(Figure 1). The hand search identiied 2
further studies, resulting in a total of 124
studies. During the screening process,
studies were removed as follows: irstly,
75 studies were excluded as within the
title, they investigated different monitor-
ing methods, hypothermia generally or
involved liver failure/cardiac arrest situa-
tions. Secondly, following abstract review,
a further 20 studies were excluded as they
did not adhere to the inclusion/exclusion
criteria. The remaining 29 studies were read
in full, and 21 were excluded as they did
not match the inclusion/exclusion criteria
of primary research and involving TBI.
Therefore, eight studies were identiied via
the search process.
The eight identiied studies involved
689 patients and consisted of six RCTs,
two of which were multi-centred, and two
quasi-experimental studies involving ret-
rospective comparisons against historical
control data (Table 1). Six studies compared
the effectiveness of TH against the use of
normothermia; one compared the effec-
tiveness of long-term (5 days) TH against
short-term (2 days) TH; and a further study
compared the effectiveness of TH main-
tained at 35∘C as opposed to 33∘C. Inclusion
and exclusion criteria varied between the
studies as well as the methods of induc-
ing and managing TH. Following critical
appraisal, four common themes emerged:
1. Inluence on neurological outcome.
2. Inluence on ICP.
3. Correlation between neurological out-
come and brain pathology.
4. Complications.
Inluence on neurological outcome
As with previous reviews, it was found that
the inluence on neurological outcome of
TH is conlicting, with some studies show-
ing a beneit and others not; this may be
due to variations in study design and when
outcomes were measured. All eight studies
measured neurological outcome using the
Glasgow outcome score (GOS) (Jennet and
Bond, 1975), although at varying periods
after initial injury (6 months to 2 years).
All studies considered a score of ≥4 as
a favourable outcome and a score ≤3 as
an unfavourable outcome. Three studies
concluded that TH improves neurologi-
cal outcome with statistical signiicance
(Smrcˇka et al., 2005; Inamasu et al., 2006;
Lee et al., 2010). Lee et al. (2010) reported
a favourable outcome in 71⋅4% of patients
managed with TH in conjunction with PtiO2
(brain tissue oxygenation)-guided manage-
ment of cerebral perfusion pressure (CPP),
60% in the TH group without PtiO2-guided
management and 50% in the normothermia
group (p= 0⋅04). However, the use of three
treatment strategies makes it dificult to dis-
tinguish whether the improved outcomes
were because of the guided CPP manage-
ment or TH, and the sample size is limited.
Inamasu et al. (2006) also reported a higher
rate of favourable outcome in patients
treated with TH compared to normother-
mia; 27⋅8% of patients treated with TH had
a favourable outcome, with a survival rate
of 33⋅3% compared to 6⋅7% of patients in the
normothermia group (p< 0⋅05). However,
the study design and sample size offers
questionable reliability. Smrcˇka et al. (2005)
likewise reported a statistically signiicant
increase in GOS score in the TH group com-
pared to the normothermia group (p= 0⋅01);
however, there are gaps in the reporting
of TH protocols, such as re-warming rates,
and their deined physiological goals, such
as ICP and CPP, which may differ from the
other studies.
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Records identified through
database searching
(MEDLINE, PubMed; CINAHL;
Cochrane Library
(n =145) 
Additional records identified
through other sources
(n = 2)
Records after duplicates removed
(n =124)
Records screened
(n = 49)
Records excluded
(n = 75) (inclusion/
exclusion criteria not met
Records excluded
(n = 20) (inclusion/
exclusion criteria not met)
Full-text articles
assessed for eligibility
(n = 29) 
Full-text articles
excluded, with
reasons-
not primary data,
not TBI related,
(n = 21)
Studies included in
quantitative synthesis
(n = 8 )
Id
e
n
ti
fi
c
a
ti
o
n
Id
e
n
ti
fi
c
a
ti
o
n
S
c
re
e
n
in
g
S
c
re
e
n
in
g
E
lig
ib
ili
ty
 
E
lig
ib
ili
ty
 
In
c
lu
d
e
d
 
In
c
lu
d
e
d
 
Figure 1 Study selection process.
In contrast, three studies concluded that
there is no statistically signiicant evidence
that TH improves overall neurological out-
come in patients with TBI (Qui et al., 2005;
Qiu et al., 2007; Clifton et al., 2011); however,
a higher rate of favourable outcome in the
TH groups was found. Clifton et al. (2011)
reported no statistical difference in the rate
of poor outcome between the TH group
and normothermia group (60 and 56%,
respectively, p= 0⋅67), and no difference
was observed in mortality rates between
the two groups (23 and 18%, respectively,
p= 0⋅52). However inconsistency in the
treatment between both groups in regards
to evacuation of haematomas may have
inluenced the indings and creates a bias
in this RCT. Clifton et al. (2011) reported
that 33% of the patients in the TH group
had craniotomies compared to 46% in the
normothermia group, which may have
inluenced the incidence of rebound IH and
affected the neurological outcome between
the two groups. Qui et al. (2005) reported
that 53⋅5% had a favourable outcome in
the TH group compared to 27⋅9% in the
normothermia group (p< 0⋅05), indicating
that TH was effective at improving neuro-
logical outcome; however, there are some
inconsistencies in the study design and a
small sample size. Qiu et al. (2007) reported
similar igures. However, despite the sta-
tistical signiicance, neurological outcome
was assessed at different times (ranging 6
months to 2 years in all studies); therefore,
patients had a substantially longer time to
recover compared to others, which would
inluence results.
Jiang et al. (2006) and Tokutomi et al.
(2009) evaluated the inluence duration and
temperature of TH has on neurological out-
come respectively. Jiang et al. (2006) reported
that long-term (5 days) TH improved the
rate of favourable neurological outcome
compared to short-term (2 days) TH (43⋅5%
versus 29%, p< 0⋅05), suggesting that longer
periods of cooling are more eficacious. This
was a multi-centred RCT with a reasonable
sample size, so these results have a greater
reliability than other studies. Tokutomi
et al. (2009) reported weak evidence that the
mortality rate was lower in the 35∘C group
(p= 0⋅08), suggesting that the milder tem-
perature caused lower risk to the patients.
However, this study used historical data
as the control, which leads to questionable
reliability of these indings.
Inluence on ICP
All the studies reviewed monitored ICP,
with ive reporting that TH signiicantly
lowered ICP during TH compared to treat-
ment with normothermia (Qui et al., 2005;
Smrcˇka et al., 2005; Inamasu et al., 2006;
Qiu et al., 2007; Lee et al., 2010). However,
only Lee et al. (2010) demonstrated a sus-
tained decrease in ICP levels following
re-warming; this was the only study to
titrate re-warming in relation to rebound IH
and opted to re-induce hypothermia when
ICP values increased. Jiang et al. (2006)
found that ICP signiicantly rebounded
after re-warming in the short-term TH
group and was signiicantly higher there-
after compared to the long-term TH group
(p< 0⋅05). Tokutomi et al. (2009) found
that TH maintained at 35∘C and 33∘C both
controlled ICP under 20mmHg, with no sig-
niicant differences in the incidence of IH;
however, ICP did rebound above 20mmHg
in both groups 8 days after injury. Clifton
et al. (2011) reported the only adverse effect
on ICP, with a signiicantly higher incidence
of IH compared to the normothermia group
(71% versus 60%, p= 0⋅003).
These indings suggest that TH does help
to reduce ICP, but this does not consistently
have a lasting effect. If rebound IH occurs
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Table 1 Primary research on effectiveness of therapeutic hypothermia in patients with traumatic brain injury from 2004 onwards
Author and year Setting Study design Sample Methods Findings Implications for practice
Qui et al. (2005) Hangzhou Second
Hospital, China
Single-centre RCT 86 patients aged 19–65
with severe TBI
confirmed by CTwithin
24 h of injury and a
GCS of ≤8
Patients were randomized into
two groups: treatment with
hypothermia (n= 43) and
treatment with
normothermia (n= 43).
Hypothermia was
maintained between 33∘C
and 35∘C for 3–5 days and
passively re-warmed.
Influence of hypothermia
on vital signs, extradural
pressure (EDP), serum
superoxide dismutase
(SOD), complications and
GOS score 2 years after
injury was analysed
There was a significantly higher rate of
favourable outcome and lower mortality
rate in the hypothermia group compared
to the normothermia group. EDP values
were significantly lower at 24, 48 and
72 h post-injury in the hypothermia
group, whilst the highest EDP was
observed at 48 h post-injury in both
groups. Serum SOD levels were
significantly higher at days 3 and 7
compared to the normothermia group.
Patients who underwent surgical
decompression had a lower mortality
rate in the hypothermia group compared
to the normothermia group. There was
no evidence indicating there is a
significantly higher incidence of severe
complications in patients treated with
therapeutic hypothermia; however, there
was a higher incidence of pulmonary
infection and thrombocytopenia in the
therapeutic hypothermia group
There is evidence that
therapeutic mild
hypothermia reduces ICP,
increased serum SOD levels
and improves neurological
outcome without severe
complications
Smrcˇka et al. (2005) University Hospital
Brno, Czech
Republic
Single-centre RCT 72 patients aged
<60 years with severe
TBI and a GCS of ≤8
Patients were randomized into
two groups: treatment with
hypothermia (n= 35) and
treatment with
normothermia (n= 37).
Hypothermia was
maintained at 34∘C for 3
days. Influence of
hypothermia on ICP, CPP
and GOS score 6 months
after injury was analysed
The use of hypothermia significantly
decreased ICP, SvjO2 and increased CPP.
There were significantly more favourable
outcomes in the hypothermia group
compared to the normothermia group.
Hypothermia was more beneficial in
patients with extra-cerebral haematomas
compared to patients with primary brain
lesions
Therapeutic hypothermia
significantly improves the
outcome in patients with
extra-cerebral haematomas.
Therapeutic hypothermia in
patients with primary brain
lesions should be used in
cases with otherwise
intractable intracranial
hypertension
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Table 1 Continued
AQ3
Author and year Setting Study design Sample Methods Findings Implications for practice
Inamasu et al. (2006) National Tokyo
Medical Centre,
Japan
Quasi-experimental
(using historical
control group)
33 severely head-injured
patients with ASDH
and a GCS score of ≤6
on admission and
treated with
haematoma evacuation
Patients who met the inclusion
and exclusion criteria were
treated with therapeutic
hypothermia (n= 18).
Hypothermia was
maintained between 34∘C
and 35∘C for 3 days. The
effect of hypothermia was
evaluated retrospectively by
comparing the outcome
with a historical control
with similar injury and
treatment (n= 15) that
were treated with
normothermia. The
outcome of all patients was
evaluated using the GOS
score at 6 months. Effect
on ICP was also considered
Patients treated with therapeutic
hypothermia had significantly lower ICP,
higher survival rate and more favourable
outcome compared to the historical
control group. Therapeutic hypothermia
was more effective at improving
outcome of patients with haematomas
compared to patients with contusion.
Patients with a GCS score of 5 or 6 and
treated with therapeutic hypothermia
had a higher survival rate compared to
patients with a GCS of 3 or 4
Therapeutic hypothermia is
potentially efficacious post
operatively in patients with
ASDH who have undergone
haematoma evacuation and
without concomitant
cerebral contusion.
Jiang et al. (2006) Three medical centres
in China
Multi-centred RCT 215 patients aged 18–45
years old with
non-penetrating severe
TBI with cerebral
contusion and
intracranial
hypertension and a
GCS of≤ 8 within 4 h
of admission.
Patients were randomized into
two groups: long-term
hypothermia (5 days,
n= 108) and short-term
hypothermia (2 days,
n= 107). Hypothermia was
maintained at 33∘C–35∘C
in both groups and both
were re-warmed no faster
than 1∘C per h. The
neurological outcome of all
patients was assessed using
the GOS score 6 months
after injury. Effect on ICP
and incidence of
complications were also
evaluated
Patients treated with long-term therapeutic
hypothermia had a higher rate of
favourable outcomes compared to the
short-term group. The ICP of patients in
the short-term group rebounded after
re-warming and was significantly higher
compared to the long-term group. There
was no significant difference in the
incidence of complications between the
two groups
Long-term therapeutic
hypothermia is more
effective at controlling
refractory intracranial
hypertension than
short-term therapeutic
hypothermia
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354
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Table 1 Continued
AQ4
Author and year Setting Study design Sample Methods Findings Implications for practice
Qiu et al. (2007) Hangzhou Second
Hospital, China
Single-centre RCT 80 patients aged 19–65
with severe
non-penetrating TBI
confirmed by CTwithin
6 h of injury, a GCS of
≤8 having undergone
craniotomy
Patients were randomized into two
groups: treatment with
hypothermia (n= 40) and
treatment with normothermia
(n= 40). Hypothermia was
maintained between 33∘C and
35∘C for 4 days and passively
re-warmed. Influence of
hypothermia on vital signs, ICP,
SOD, complications and GOS
score 1 year after injury was
analysed
There was a significantly higher rate of
favourable outcome in the hypothermia
group compared to the normothermia group.
ICP values measured in the hypothermia
group were significantly lower compared to
the normothermia group at 24, 48 and 72 h
post-injury. The highest ICP was measured at
48 h post-injury. Serum levels of SOD were
significantly higher in the hypothermia group
compared to the normothermia group. There
was no evidence indicating that there is a
significantly higher incidence of severe
complications in patients treated with
therapeutic hypothermia; however, there was
a higher incidence of pulmonary infection
and thrombocytopenia in the therapeutic
hypothermia group
Therapeutic hypothermia
reduces ICP, increases
serum SOD levels and
improves neurological
outcome in patients with
severe TBI; however, there
is an indication of increased
risk of pulmonary infection
and thrombocytopenia.
Large randomized studies
are required to further
investigate the efficacy of
therapeutic hypothermia
after craniotomy
Tokutomi et al. (2009) Japan Quasi-experimental
study (using
historical control)
61 patients aged 15–70
years with severe TBI
and a GCS of ≤5
Patients who met the
inclusion/exclusion criteria were
treated with hypothermia
maintained at 35∘C for 48–72
h if ICP was controlled under
20 mmHg (n= 30). The effect
of hypothermia at 35∘C was
evaluated retrospectively by
comparing the outcome with a
historical control of were
treated with hypothermia
maintained at 33∘C (n= 31).
Influence of hypothermia on ICP,
CPP, biochemical markers, and
GOS score 6 months after injury
Mean ICP values did not differ statistically
between the two groups. The incidence of
intracranial hypertension and low CPP did
not differ between the two groups although
CPP was controlled at a slightly higher level in
the 35∘C group. Patients in the 33∘C
hypothermia group had significantly lower
serum potassium levels on days 3 and 5
compared to the 35∘C group. The mean CRP
values on days 14 and 21 were also
significantly lower in the 35∘C group, whilst
there high CRP levels were more prolonged
in the 33∘C group. There were no significant
differences in neurological outcome between
the two groups; however, there was a
tendency of increased incidence of
complications and higher mortality rate in the
33∘ group
Therapeutic hypothermia
maintained at 35∘C is
sufficient at controlling ICP
and is safer and as effective
as hypothermia at 33∘C
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354
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Table 1 Continued
Author and year Setting Study design Sample Methods Findings Implications for practice
Lee et al. (2010) China Medical
University Hospital,
Taiwan
Single-centre RCT 45 patients aged 12–70
with severe TBI
confirmed by CTwithin
4 h of admission and a
GCS of 4 to 8.
Patients were randomized into
three groups: normothermia
with (group A, n= 16),
therapeutic hypothermia (group
B, n= 15) and therapeutic
hypothermia with PtiO2 guided
management (group C, n= 14).
Hypothermia was maintained
between 33∘C and 35∘C for 5
days. GOS score, ICP, PtiO2,
length of hospital stay and
complications were analysed
Groups B and C had more favourable outcomes
and lower mortality rates compared to the
normothermia group. ICP values in the
groups B and C increased less in the first 3
days post-injury and were significantly lower
than those in the group A. ICP peaked at 72
h in group A group compared to 24–48 h in
the groups B and C. It was found that PtiO2
values increased as ICP values decreased. The
mean ICU stay was shorter in group A;
however, the total hospital stay was shortest
in group C
Therapeutic hypothermia in
conjunction with PtiO2
guided CPP and ICP
management is beneficial
in treating TBI, warranting
further research using a
multi-centre RCT
Clifton et al. (2011) Six medical centres in
the United States
and Canada
Multi-centred RCT 97 patients aged 16–45
years with
non-penetrating severe
TBI with a GCS of ≤8
on admission
Patients were randomized into two
groups: early induction of
hypothermia (n= 52) and
patients maintained at
normothermia (n= 31). The
hypothermia group were cooled
to 33∘C for 48 h and
re-warmed at a rate of 0⋅5∘C
every 2 h regardless of ICP. The
primary outcome measured was
neurological outcome measured
with the Glasgow outcome
score at 6 months. The
therapeutic intervention score
quantifying the intensity of
interventions, effect on ICP,
incidence of complications and
various laboratory data were
also compared
There was no significant difference in outcome
between the two groups. The hypothermia
group had a significantly higher incidence of
increased ICP compared to the normothermia
group. Patients in the hypothermia group
required more interventions for ICP control in
the first 96 h and more interventions in total.
Patients treated with surgical removal of
haematoma and treated with hypothermia
had significantly fewer poor outcomes
compared to the normothermia group.
Patients with diffuse brain injury and treated
with hypothermia had a higher rate of poor
outcomes compared to the normothermia
group. There was a significant difference in
the incidence of complications in the two
groups
There is no further need for
investigation of early
therapeutic hypothermia as
a neuroprotectant. The use
of therapeutic hypothermia
used in conjunction with
evacuation of haematomas
requires further
investigation
CT, computed tomography; CPP, cerebral perfusion pressure; GCS, Glasgow coma scale; RCT, randomized controlled trial; TBI, traumatic brain injury; ICP, intracranial pressure.
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during re-warming, re-inducing the THmay
be helpful. Titration of re-warming against
response to changes in ICP may again be
helpful, but the evidence supporting this is
limited.
Correlation between neurological
outcome and brain pathology
Three studies investigated the correlation
between brain pathology and neurologi-
cal outcome, inding that patients with a
haematoma and treated with TH had better
neurological outcomes than patients with
primary brain injury only (Smrcˇka et al.,
2005; Inamasu et al., 2006; Clifton et al., 2011).
Clifton et al. (2011) reported a higher rate of
favourable outcome in patients treated with
TH and surgical removal of intracranial
haematomas compared to patients with
diffuse brain injury (p= 0⋅01). Further anal-
ysis identiied that patients treated with
surgical removal of haematomas had better
outcomes when treated with TH instead of
normothermia (p= 0⋅02), and patients with
diffuse injury had poorer outcomes in the
TH group compared to the normothermia
group (p= 0⋅09) and a higher mortality
rate (p= 0⋅08) (Clifton et al., 2011). Further-
more, IH was more common in patients
with diffuse brain injury and treated with
TH compared to normothermia (p= 0⋅003),
suggesting that TH is not as effective with
diffuse brain injury. Both Inamasu et al.
(2006)and Smrcˇka et al. (2005) found that
patients with haematoma-type injuries had
better outcomes and survival rates com-
pared to patients with contusions when
treated with TH compared to normother-
mia (p< 0⋅05). Their indings suggest that
patients with contusions do not beneit from
treatment with TH.
These studies, although limited, suggest
that TH is more effective with haematomas;
when considering other reviews, this sug-
gestion is not explicit.
Complications
There are potential complications of TH;
however, ive of the studies concluded that
TH was not associated with severe compli-
cations (Qui et al., 2005; Smrcˇka et al., 2005;
Qiu et al., 2007; Lee et al., 2010; Clifton et al.,
2011). Pulmonary infection was the com-
plication with the highest incidence in the
studies, with the exception of Clifton et al.
(2011) who reported a signiicantly higher
rate of overall complications, such as IH
and infection in the TH group (408 episodes
versus 208, p= 0⋅01); however, this was
inluenced by the high incidence of IH in the
TH group, whilst infectious, cardiovascular
and bleeding complications showed no sig-
niicant difference. Qui et al. (2005) observed
a higher incidence of pulmonary infection
in the TH groups compared to the normoth-
ermia groups (60⋅5% versus 39⋅5%, p< 0⋅05),
with similar indings by Qiu et al. (2007)
(57⋅5% versus 32⋅5%, p= 0⋅025). Addition-
ally, Tokutomi et al. (2009) found evidence
that patients cooled at a lower temperature
(33∘C compared to 35∘C) were more suscep-
tible to pneumonia (p= 0⋅09); however, this
was not statistically signiicant.
Three studies noted an increase in coag-
ulopathies in patients treated with TH. Qui
et al. (2005) and Qiu et al. (2007) observed
thrombocytopenia in 62⋅8% and 57⋅5%,
respectively, of patients treated with TH.
Clifton et al. (2011) noted decreases in par-
tial thromboplastin times (PTT) (p= 0⋅004),
although these were slight, and there was
no signiicant difference in bleeding compli-
cations between the TH and normothermia
groups.
Serum potassium level abnormalities in
the TH groups were noted in two stud-
ies. Clifton et al. (2011) reported minor but
signiicant decreases in mean serum potas-
sium levels in the TH group (3⋅6 versus
3⋅8mmol/L, p= 0⋅0005). Tokutomi et al.
(2009) also reported decreases in serum
potassium levels in patients cooled to 33∘C
compared to 35∘C, most signiicantly on
day 5 post-injury (3⋅7 versus 4⋅0mmol/L
respectively, p= 0⋅005). Interestingly, both
studies cooled their patients to 33∘C, whilst
others used milder temperatures, therefore
highlighting a possible interaction between
TH depth and serum potassium abnormal-
ity. This has clear clinical implications with
regards to the depth of TH.
DISCUSSION
Inluence on neurological outcome
This review suggests that TH may improve
neurological outcome in patients with TBI;
however, the results from the studies are
varied with contradictions regarding its efi-
cacy. The studies are of variable quality, with
little explanation of randomization methods
and allocation concealment affecting the
reliability and validity of results, whilst the
small samples sizes means that indings
cannot be conidently generalized to the
wider population (Parahoo, 2014). Perhaps
the highest quality study in this review,
Clifton et al. (2011), concluded that TH is not
effective at improving neurological outcome
and has no basis for further research. Never-
theless, there are still undeniable trends that
demonstrate that TH increases GOS scores
and reduces mortality rates. With regards to
neurological outcome, the indings of this
review are consistent with current system-
atic reviews and meta-analyses (McIntyre
et al., 2003; Alderson et al., 2004; Peterson
et al., 2008; Pengcheng and Chaohua, 2014),
which all identify a trend towards a posi-
tive inluence on neurological outcome and
acknowledge that there is a lack of unifor-
mity with regards to TH protocols among
the studies.
Within the studies, there are variations
relating to methods of inducing TH, target
temperature, duration of cooling and rate
of re-warming, all of which are key fac-
tors known to inluence neurological out-
come (Finkelstein and Alam, 2010). It is
accepted that TH must be induced as early
as possible in order to be of beneit (Clifton
et al., 2001, 2011; Bersten et al., 2014). Neu-
ronal death is known to occur within hours
following primary brain injury compared
to several days for secondary brain injury
as a result of ischaemic damage (Berger
et al., 2006). It is therefore interesting that
Clifton et al. (2011), a study which reported
the most rigorous protocols for early induc-
tion, did not ind a positive relationship
between TH and neurological outcome. The
eficacy of early-induced TH can be consid-
ered in relation to the pathogenesis of TBI.
Bersten et al. (2014) outline three phases of
TBI and changes in CBF and ICP spanning
2 weeks post-injury. THwould inluence the
irst two phases:
1. The irst 72 h (hypoperfusion phase)
after initial injury marks a decrease in
CBF and resultant global/regional
ischaemia because of impaired
autoregulation, which requires an
adequate systemic blood pressure in
order to maintain CPP.
2. This is followed by the hyperaemic
phase during which autoregulation
mechanisms may start to recover in
some patients, resulting in improved
CBF. However, any hyperaemia com-
bined with intracranial inlammation
and compromised BBB permeabil-
ity can result in vasogenic cerebral
oedema, and therefore, therapies that
aim to maintain CBF may potentiate
the occurrence of IH (Bersten et al.,
2014).
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In this context, TH may be more effec-
tive 72 h post-injury when CBF is more
controlled, especially as TH is associated
with hypotension and may further com-
promise CBF during the initial hypoperfu-
sion stage (Polderman, 2008). This correla-
tion has not previously been considered in
other reviews.
Duration of cooling is also considered
to inluence neurological outcome (McIn-
tyre et al., 2003). Jiang et al. (2006) observed
that patients who were cooled for 5 days
had signiicantly better neurological out-
comes compared to patients cooled for 2
days. Two meta-analyses found that only
TH maintained for longer than 48 h was
associated with a lower mortality rate and
improved neurological outcome (McIntyre
et al., 2003; Bratton et al., 2008). The optimal
duration of TH is unknown; however, this
review suggests that TH is more effective
when instituted for longer than 48 h. The
ability to cope with an increased ICP dif-
fers from person to person (McLeod, 2004),
therefore requiring individualized man-
agement and reassessment of re-warming
rates depending on initial responses of
ICP, which has nursing implications. It is
therefore unsurprising that Lee et al. (2010)
was successful in improving neurologi-
cal outcome by re-warming patients only
when the ICP returned to acceptable levels
and cooling for a further 48 h if there was
indication that ICP was rebounding; this
is, however, a small study involving one
centre. A previous study adopted a similar
protocol with positive results by slowing
or stopping re-warming when ICP began
to increase, noting an average duration of
4⋅8days and even up to 21 days in some
patients (Polderman et al., 2002). However,
this recommendation is not within current
clinical guidelines and should be considered
by clinicians.
Inluence on ICP
All studies, with the exception of Clifton
et al. (2011), found that TH was effective
at reducing ICP. Clifton et al.’s (2011) ind-
ings were unique in that the TH group
had a higher incidence of IH compared to
the normothermia group; however, lower
doses ofmorphine and higher doses of vaso-
pressors were used to reduce TH-induced
hypotension as observed in their previous
study (Clifton et al., 2001). Most studies used
surgical decompression and external ven-
tricular drainage when ICP could not be
controlled. It is therefore dificult to ascer-
tainwhether THor other interventions inlu-
enced decreases in ICP.
This review has, however, identiied a
link between the duration of cooling and
the occurrence of rebound IH. Jiang et al.
(2006) found that ICP was more likely to
rebound during re-warming when TH was
maintained for 48 h. This may be because
of exacerbation of the hyperaemia phase
by early re-warming causing a subsequent
increase in CBF, which may then cause ICP
to rebound (Bersten et al., 2014). It is also
acknowledged that reduced ICP does not
necessarily correlate to improved neuro-
logical outcome (Stocchetti et al., 2015) as
TH is also considered to improve outcome
through prevention of neuronal death and
attenuation of various chemical cascades
(Polderman, 2004).
Correlation between neurological
outcome and brain pathology
There is a trend of improved neurological
outcome in patients with haematoma-type
lesions compared to patients with diffuse
brain injury and contusions. This is sup-
ported by previous studies, which also
reported that the effectiveness of TH in
patients with extra-cerebral haematomas
correlated to the degree of midline shift,
whereas patients with focal cerebral lesions
were found to beneit the most from TH
(Shiozaki et al., 1998, 2003).
Complications
Fewer complications and an improved
mortality rate were associated with TH at
35∘C compared to cooling at 33∘C (Toku-
tomi et al., 2009), which has implications
with regards to the recommended depth of
TH. It is known that lower temperatures
increase the likelihood of severe complica-
tions such as severe ventricular arrhythmias
and hypokalaemia (Clifton et al., 1992, 1993;
Wright, 2005). Hypokalaemia was docu-
mented in studies cooling patients to 33∘C,
suggesting a link to lower temperature
management (Tokutomi et al., 2009; Clifton
et al., 2011). Additionally, two studies noted
higher incidence of thrombocytopenia in
the TH groups (Qui et al., 2005; Qiu et al.,
2007), whilst Clifton et al. (2011) reported
a slight but signiicant increase in PTT,
indicating an increased risk of bleeding.
Coagulopathies are known complications
of TH; however, the incidence is variable
(Finkelstein and Alam, 2010). Interestingly,
none of the studies addressed the effects of
TH on glycaemic control, despite its impor-
tance in head-injured patients (Bersten et al.,
2014). TH is known to cause insulin resis-
tance and decreased production causing,
hyperglycaemia (Polderman, 2004). Glucose
control is an area requiring further research
in the context of TH and TBI.
Limitations
The main limitation of this review is the dis-
tinct variation in protocols between the eight
studies, making comparison dificult and
indings less generalizable. There are gaps
in data reporting, predominately relating to
the time taken to induce TH and re-warming
rates, leading to insuficient data to fully
analyse the effects of TH. Aside from the
differences in TH management, variations
exist in the use of co-interventions such
as surgical decompression and ventricular
drainage as well as inclusion/exclusion cri-
teria between the studies, making it difi-
cult to concludewhether any positive effects
are because of TH, co-interventions or dif-
ferences in sample demographics or disease
severity. Six of the eight studies were con-
ducted in Asia, so consideration of transfer-
ability of results to other health care systems
is required.
IMPLICATIONS AND
RECOMMENDATIONS FOR
PRACTICE
Clinically, it is dificult to conidently rec-
ommend the use of TH because of the
variable quality of studies and differ-
ences between management protocols and
patient characteristics. However, the need
for individualized TH management has
been highlighted. The ability to cope with
increased ICP differs between patients and
is inluenced by the protocols of TH induc-
tion, duration and time of re-warming.
Of particular note is the role of autoreg-
ulation and the inluence temperature
management has on cerebral haemodynam-
ics. In short, the key messages from this
review are that patients need to be cooled
soon enough, long enough and re-warmed
slowly depending on ICP responses in order
to effectively improve neurological outcome
and reduce the risk of complications. Cur-
rent clinical guidelines do not make these
recommendations explicit.
Further prospective multi-centred RCTs
are needed to fully investigate the ben-
eicial effects of TH. This review has
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highlighted areas for further research:
titrating target temperatures in line with
cerebral haemodynamic changes known to
occur with TBI and further investigation of
the eficacy of TH depending on the type
of brain injury. Additionally, multi-centred
RCTs would reduce inter-centre variance
of TH management and ensure that the
research protocols are consistent, therefore
enabling accurate analysis of results.
Conclusion
Despite the lack of high-quality research,
this review shows that TH may improve
neurological outcome in patients with TBI,
with low risk of severe complications. This
review suggests that patients with contu-
sions demonstrate little or no beneit from
receiving TH in place of normothermia treat-
ment. It also suggests that a longer duration
of cooling may be beneicial, and continua-
tion of cooling should be considered by the
clinical teams if rebound IH occurs.
WHAT IS KNOWN ABOUT THIS TOPIC
• Research has shown variable effectiveness
of TH following traumatic head injury in
improving patient outcome.
• TH does not necessarily have a sustained
effect on controlling ICP.
WHAT THIS PAPER ADDS
• There needs to be an individualized approach
to TH, especially if rebound intracerebral
hypertension is observed during re-warming.
• Therapeutic hypothermic should not be
limited to 48 h, and if rebound intracerebral
hypertension is observed, there is some
evidence to suggest that recommencing TH
may be of help.
• With regards to the timing and extent
of TH, underlying alterations in cerebral
haemodynamics should be taken into
consideration.
• TH may be more effective in improving
patient outcome when haematomas have
developed as opposed to patients with
cerebral contusions and/or diffuse injuries.
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